Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China flag China · Delayed Price · Currency is CNY
12.90
+0.28 (2.22%)
May 29, 2026, 3:04 PM CST

SHE:000403 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
435.53770.161,3211,4291,001885.67
Trading Asset Securities
263.71254.39282.7423.34422.44234.21
Cash & Short-Term Investments
699.241,0251,6041,8531,4231,120
Cash Growth
-50.70%-36.12%-13.43%30.18%27.09%989.09%
Accounts Receivable
966.611,089710.69592.77891.08581.12
Other Receivables
8.449.176.542.3449.7112.83
Receivables
975.051,098717.19635.11940.79593.95
Inventory
1,7921,5781,245924.06623.69738.97
Prepaid Expenses
-18.9311.3712.350.140
Other Current Assets
84.141.241.611.8759.1216.53
Total Current Assets
3,5503,7213,5793,4263,0472,469
Property, Plant & Equipment
2,0462,0721,9991,5541,2971,103
Long-Term Investments
--6---
Goodwill
2,5362,5362,6152,6152,6152,615
Other Intangible Assets
187.16190.22200.33212.59192.52200.05
Long-Term Deferred Tax Assets
27.2826.5829.4349.0449.0927.35
Long-Term Deferred Charges
241.63229.9153.5579.4789.767.42
Other Long-Term Assets
793.92690.46664.24694.87692.81605.82
Total Assets
9,3839,4669,2468,6307,9827,088
Accounts Payable
133.71155.26224.26154.35158.37158.7
Accrued Expenses
35.33311.19335.48372.84373.49239.21
Short-Term Debt
536.31535.7310.49250.57275.1113.52
Current Portion of Long-Term Debt
75.1359.8417.0621.228.63-
Current Portion of Leases
-2.755.066.677.147.05
Current Income Taxes Payable
36.1715.5819.0739.7243.0824.22
Current Unearned Revenue
3.693.046.3610.7625.9111.54
Other Current Liabilities
232.3145.1239.266.0667.5888.04
Total Current Liabilities
1,0531,128956.97922.19959.31642.29
Long-Term Debt
161.85193.83303.22196.0852.89-
Long-Term Leases
13.811.9418.621.4829.5920.89
Long-Term Unearned Revenue
37.4836.9726.8435.640.0849.24
Long-Term Deferred Tax Liabilities
12.9613.8714.1324.2630.3336.52
Other Long-Term Liabilities
--99911.14
Total Liabilities
1,2791,3851,3291,2091,121760.07
Common Stock
950.4950.4731.07733732.39732.92
Additional Paid-In Capital
4,5394,5394,758-4,7794,779
Retained Earnings
2,6222,5992,4351,9461,392846.23
Treasury Stock
----43.17-36.22-32
Comprehensive Income & Other
0.030.040.054,7930.04-0
Total Common Equity
8,1118,0887,9257,4296,8686,326
Minority Interest
-7.02-6.78-7.15-6.79-6.42.07
Shareholders' Equity
8,1048,0817,9187,4226,8616,328
Total Liabilities & Equity
9,3839,4669,2468,6307,9827,088
Total Debt
787.09804.06654.44496.02373.36141.46
Net Cash (Debt)
-87.85220.48949.391,3571,050978.42
Net Cash Growth
--76.78%-30.02%29.22%7.30%-
Net Cash Per Share
-0.090.230.991.431.101.06
Filing Date Shares Outstanding
950.4950.4950.4950.06952.1952.8
Total Common Shares Outstanding
950.4950.4950.4950.34952.1952.8
Working Capital
2,4982,5932,6222,5042,0881,827
Book Value Per Share
8.538.518.347.827.216.64
Tangible Book Value
5,3885,3625,1104,6014,0603,511
Tangible Book Value Per Share
5.675.645.384.844.263.68
Buildings
-1,2661,180833.6701.14583.25
Machinery
-1,5631,184961.1920.37729.45
Construction In Progress
-225.99513.36582.7385.73334.38